Skip to main content

Advertisement

SpringerLink
Log in

Vaccination Priorities in Travel

  • Introduction
  • Published:
BioDrugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1
Table III

References

  1. Steffen R, Banos A, de Bernardis C. Vaccination priorities. Int J Antimicrob Agents 2003; 21: 175–80

    Article  PubMed  CAS  Google Scholar 

  2. World Tourism Organisation. Tourism highlights 2002 [online]. Available from URL: http://www.world-tourism.org/market_research/facts&figures/latest_data/Mje.%20Highlights%202002%20INGLES.pdf [Accessed 2003 Jan 29]

  3. Zuckerman JN. Are there priorities in travel vaccinations [abstract 49]? In: Travel & Epidemics. 3rd European Conference on Travel Medicine; 2002 May 15–18; Florence, Italy

  4. Steffen R. Evaluation of the current status of travel health knowledge, attitudes and practices (KAP) among travellers [abstract 51]. In: Travel & Epidemics. 3rd European Conference on Travel Medicine; 2002 May 15–18; Florence, Italy

  5. Centres for Disease Control and Prevention. Health information for international travel, 2001–2002. Atlanta (GA): US Department of Health and Human Services, 2001

    Google Scholar 

  6. World Health Organisation. International travel and health. Geneva: World Health Organisation, 2003

    Google Scholar 

  7. World Health Organisation. International travel and health. Geneva: World Health Organisation, 2002

    Google Scholar 

  8. Galazka A. The changing epidemiology of diphtheria in the vaccine era. J Infect Dis 2000; 181Suppl. l: S2–9

    Article  PubMed  Google Scholar 

  9. Löscher T, Keystone JS, Steffen R. Vaccination of travelers against hepatitis A and B. J Travel Med 1999; 6: 107–14

    Article  PubMed  Google Scholar 

  10. Zuckerman JN, Steffen R. Risks of hepatitis B in travelers as compared to immunization status. J Travel Med 2000; 7: 170–4

    Article  PubMed  CAS  Google Scholar 

  11. Rota JS, Rota PA, Redd SB, et al. Genetic analysis of measles viruses isolated in the United States, 1995–1996. J Infect Dis 1998; 177: 204–8

    Article  PubMed  CAS  Google Scholar 

  12. Steffen R, Kane MA, Shapiro CN, et al. Epidemiology and prevention of hepatitis A in travelers. JAMA 1994; 272: 885–9

    Article  PubMed  CAS  Google Scholar 

  13. World Health Organization. Rabies, Asia. Wkly Epidemiol Rec 2001; 76: 320–3

    Google Scholar 

  14. Haupt W. Rabies: risk of exposure and current trends in prevention of human cases. Vaccine 1999; 17: 1742–9

    Article  PubMed  CAS  Google Scholar 

  15. Steffen R. Typhoid vaccine, for whom? Lancet 1982; I: 615–6

    Article  Google Scholar 

  16. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985–1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998; 158: 633–8

    Article  PubMed  CAS  Google Scholar 

  17. Caumes E, Ehya N, Nguyen J, et al. Typhoid and paratyphoid fever: a 10-year retrospective study of 41 cases in a Parisian hospital. J Travel Med 2001; 8: 293–7

    Article  PubMed  CAS  Google Scholar 

  18. Koch S, Steffen R. Meningococcal disease in travelers: vaccination recommendations. J Travel Med 1994; 1: 4–7

    Article  PubMed  Google Scholar 

  19. Cobelens FG, van Deutekom H, Draayer-Jansenv IW, et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000; 356: 461–5

    Article  PubMed  CAS  Google Scholar 

  20. Rieder HL. Risk of travel-associated tuberculosis. Clin Infect Dis 2001; 33: 1393–6

    Article  PubMed  CAS  Google Scholar 

  21. Wittlinger F, Steffen R, Watanabe H, et al. Risk of cholera among western and Japanese travelers. J Travel Med 1995; 2: 154–8

    Article  PubMed  Google Scholar 

  22. Connor BA, van Herck K, van Damme P. Rapid protection and vaccination against hepatitis A for travellers. BioDrugs 2003; 17Suppl. 1: 19–22

    Article  PubMed  Google Scholar 

  23. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1996; 45(RR-15): 1–30

    Google Scholar 

Download references

Acknowledgements

J.N. Zuckerman has been reimbursed by several manufacturers of vaccines and anti-malarial prophylaxis, for attending conferences, for running educational programmes and has received unrestricted educational grants. J.N. Zuckerman is also a consultant in travel medicine to the Brisish Airways Travel Clinics.

Author information

Authors and Affiliations

  1. Academic Centre for Travel Medicine and Vaccines, Royal Free & University College Medical School, University College London, London, UK

    Jane N. Zuckerman

Authors
  1. Jane N. Zuckerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This Introduction is based on the following review: Steffen et al. Vaccination priorities. Int J Antimicrob Agents 2003; 21: 175-80. [1] Copyright 2003, with permission from Elsevier Science. This article is published with the assistance of Robert Steffen

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zuckerman, J.N. Vaccination Priorities in Travel. BioDrugs 17 (Suppl 1), 1–6 (2003). https://doi.org/10.2165/00063030-200317001-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00063030-200317001-00001

Keywords

Search

Navigation